mk2 Biotechnologies gratefully announces its support by the German Federal Ministry for Economic Affairs and Energy via the funding program EXIST-Forschungstransfer. The support will enable inevitable R&D activities, which again will promote the technological and business progress in order to further improve the revolutionary peptide synthesis technology by mk2 Biotechnologies.
mk2 Biotechnologies is the winner of the Audience Award of the European Health Catapult 2018. Being selected as one of Germany’s and Swiss’ regional finalist by EIT Health in the BioTech start-ups category, we were excited to present our company, technology and product offer and had many fruitful discussions next [...]
Being selected as one of the finalist for the Achema Gründerpreis, mk2 Biotechnologies attended this year’s Achema World Forum in Frankfurt and presented at a booth and in an oral presentation the advantages of its superior peptide synthesis technology. In several discussions with experts and enthusiasts mk2 Biotechnologies underlined its [...]
